Dopamine is an inotropic agent that has vasodilatory effects at low doses. It is a common belief that low-dose dopamine may be helpful in the prevention and treatment of acute renal failure and is ...
[6] β-blockers differ from one another, however, with regard to many pharmacologic properties, including β1/β2-adrenergic receptor selectivity and vasodilatory capabilities. David Wojciechowski ...
Members of our community have shared so many stories of positive changes in their lives while participating in clinical trials of YORVIPATH,” said Patty Keating, Executive Director of the ...
1 The β1 and β2 receptors are the primary beta-adrenergic receptors in the human cardiovascular system. Beta-blockers differ in their β1/β2-receptor selectivity and vasodilatory properties. Based on ...